article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

In 2020, we saw seven of the 20 biosimilars currently available in the US launch. The United States biosimilar market experienced a significant increase in competition in 2020. As a result of the regulatory changes that occurred in March 2020, the first potential insulin biosimilar is on the horizon. million patients.

article thumbnail

Health insurance statistics 2023

The Checkup by Singlecare

Census Bureau , 2022) The uninsured rate decreased from 2020 to 2021, with only 27.2 million people (8.3%) not having health insurance at any point during 2021. In 2020, 28.3 Census Bureau , 2022) Medicaid coverage increased by almost 1% in 2021 from 2020. ( using a private insurance plan. of kids, or 2.9

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enbrel patient assistance program

The Checkup by Singlecare

Without insurance coverage, discounts, or other financial support, Enbrel’s typical cash price is $8,430.54 Although Enbrel may seem expensive, it’s important to remember that some health insurance plans, Medicare Part D, and Medicaid plans might cover it. How much does Enbrel cost? for four 1 mL pre-filled syringes.

article thumbnail

Understanding and Adapting to the New Patient Journey

Pharma Marketing Network

In the initial flurry of adapting, brands quickly augmented their plans to drive large-scale messages to patients and prospects: how to access telehealth, insurance coverage, and more. Further, Veeva data from October 2020 showed that NBRxs were significantly lower than 2019 values. Reassess the Patient Journey.

article thumbnail

Humira patient assistance: Elligiblity, savings & more

The Checkup by Singlecare

Without healthcare coverage, Medicare, or discounts, Humira’s out-of-pocket cost can go well into four-digit territory. Fortunately, with insurance coverage and other resources, many people pay much less. “The A study published in 2020 estimated that the cost of bringing a new drug to market can range from $766 million to $2.8

article thumbnail

What HCPs think about health equity in cancer care

pharmaphorum

The topic rose to significance in the American Society of Clinical Oncology (ASCO) whereby they updated their mission statement in 2020 to “Conquering cancer through research, education, and promotion of the highest quality, equitable patient care.” Over 40% of those posts cited insurance companies alongside these access issues.

Insurance 116
article thumbnail

Breztri savings tips

The Checkup by Singlecare

From 2017 to 2020, the hospitalization rate for people with chronic obstructive pulmonary disease (COPD) dropped significantly , from 233.6 For someone paying completely out of pocket, with no discounts or insurance coverage, Breztri costs an average of $860 for a 30-day supply. per 100,000 cases to just 101.3.